Division of Vascular and Endovascular Surgery, Department of Surgery, University of California San Francisco, San Francisco, Calif.
Division of Vascular and Endovascular Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Mass.
J Vasc Surg. 2020 Mar;71(3):889-895. doi: 10.1016/j.jvs.2019.07.053. Epub 2019 Sep 10.
Patients undergoing lower extremity bypass (LEB) for peripheral artery disease require intensive health care resource utilization including rehabilitation and skilled nursing facilities. However, few studies have evaluated factors that lead to nonhome discharge (NHD) in this population of patients. This study sought to predict NHD by preoperative risk factors in patients undergoing LEB for peripheral artery disease using a novel risk score.
The Vascular Study Group of New England database was queried for elective LEB for peripheral artery disease including claudication and critical limb ischemia from 2003 to 2017. Patients were excluded if the procedure was not elective, if they were not admitted from home, if they were bedridden, or if they died during the index admission. Only preoperative factors were considered in the analysis. The primary end point was NHD including rehabilitation and skilled nursing facilities. Data were split two-thirds for model derivation and one-third for validation. In the derivation cohort, bivariate analysis assessed the association of preoperative factors with NHD. A parsimonious manual stepwise binary logistic regression for NHD aimed at maximizing the C statistic while maintaining model simplicity was performed. A risk score was developed using the β coefficients and applied to the validation data set. The risk score performance was assessed using a C statistic and Hosmer-Lemeshow test for model fit.
There were 10,145 cases included with an overall NHD rate of 26.4% (n = 2676). Mean age was 66 years (range, 41-90 years). NHD patients were older (72 years vs 64 years; P < .01) and more frequently male (57.2% vs 42.8%; P < .01) and nonwhite (16.1% vs 9.9%; P < .01); they more frequently had tissue loss (54.2% vs 23.0%; P < .01), anemia (16.0% vs 5.3%; P < .01), severe cardiac comorbidity (21.8% vs 10.5%; P < .01), and insulin-dependent diabetes (33.3% vs 18.2%; P < .01). On multivariable analysis, factors associated with NHD included age, sex, nonwhite race, tissue loss, cardiac comorbidity, partial ambulatory deficit, and insulin-dependent diabetes. The C statistic was 0.78 in the derivation group and 0.79 in the validation group, with Hosmer-Lemeshow P > .999. The risk score ranged from 0 to 18, with a mean score of 4 (standard deviation ±3.5). The risk score was divided into low risk (0-4 points; n = 5272 [52%]; NHD = 10.1%]), moderate risk (5-9 points; n = 3663 [36.7%]; NHD = 36.7%), and high risk (≥10 points; n = 1210 [11.9%]; NHD = 66.1%).
This novel risk score was highly predictive for NHD after LEB for peripheral artery disease using only preoperative comorbidities. High-risk patients account for 12% of LEB but nearly a third of all patients requiring NHD. This risk score can be used preoperatively to determine high-risk patients for NHD, which may help improve preoperative counseling and hospital efficiency by allocating resources appropriately.
下肢旁路术(LEB)治疗外周动脉疾病的患者需要大量的医疗资源利用,包括康复和熟练护理设施。然而,很少有研究评估导致这一人群患者非家庭出院(NHD)的因素。本研究旨在通过使用新的风险评分,预测外周动脉疾病患者行 LEB 术前的危险因素导致的 NHD。
从 2003 年至 2017 年,查询新英格兰血管研究组数据库中因跛行和严重肢体缺血等外周动脉疾病而行的择期 LEB。如果手术不是选择性的、患者不是从家中入院的、患者卧床不起或在指数入院期间死亡,则排除患者。仅在分析中考虑术前因素。主要终点是包括康复和熟练护理设施在内的 NHD。数据三分之二用于模型推导,三分之一用于验证。在推导队列中,双变量分析评估了术前因素与 NHD 的相关性。进行了一项旨在最大化 C 统计量同时保持模型简单的有选择的手动逐步二项逻辑回归 NHD。使用β系数开发风险评分,并将其应用于验证数据集。使用 C 统计量和 Hosmer-Lemeshow 检验评估模型拟合度来评估风险评分的性能。
共纳入 10145 例患者,NHD 发生率为 26.4%(n=2676)。平均年龄为 66 岁(范围,41-90 岁)。NHD 患者年龄较大(72 岁 vs 64 岁;P<.01),男性比例较高(57.2% vs 42.8%;P<.01),非白人比例较高(16.1% vs 9.9%;P<.01);他们更频繁地出现组织缺失(54.2% vs 23.0%;P<.01)、贫血(16.0% vs 5.3%;P<.01)、严重心脏合并症(21.8% vs 10.5%;P<.01)和胰岛素依赖型糖尿病(33.3% vs 18.2%;P<.01)。多变量分析显示,与 NHD 相关的因素包括年龄、性别、非白人种族、组织缺失、心脏合并症、部分活动受限和胰岛素依赖型糖尿病。在推导组中的 C 统计量为 0.78,在验证组中的 C 统计量为 0.79,Hosmer-Lemeshow P>.999。风险评分范围为 0 至 18 分,平均得分为 4(标准差±3.5)。风险评分分为低风险(0-4 分;n=5272[52%];NHD=10.1%)、中风险(5-9 分;n=3663[36.7%];NHD=36.7%)和高风险(≥10 分;n=1210[11.9%];NHD=66.1%)。
本研究使用仅术前合并症的新风险评分,可高度预测 LEB 治疗外周动脉疾病后 NHD。高危患者占 LEB 的 12%,但几乎占所有需要 NHD 的患者的三分之一。该风险评分可在术前使用,以确定 NHD 的高危患者,这有助于通过适当分配资源来改善术前咨询和医院效率。